| scholarly article | Q13442814 |
| P2093 | author name string | Poot M | |
| Gerrity RG | |||
| Bornfeldt KE | |||
| Suzuki LA | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 851-860 | |
| P577 | publication date | 2001-04-01 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels | |
| P478 | volume | 50 |
| Q37666671 | 2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis |
| Q36973815 | A cardiologist view of vascular disease in diabetes |
| Q43658451 | Adenylyl cyclase 3 mediates prostaglandin E(2)-induced growth inhibition in arterial smooth muscle cells |
| Q34002877 | Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells |
| Q35219414 | Advances and continued controversy in coronary revascularization of patients with diabetes mellitus |
| Q38451253 | Are reactive oxygen species still the basis for diabetic complications? |
| Q36857541 | Atherosclerosis in diabetes and insulin resistance |
| Q42912257 | C-Peptide in insulin resistance and vascular complications: teaching an old dog new tricks |
| Q38006686 | C-peptide: a new mediator of atherosclerosis in diabetes |
| Q36776710 | Chronic hyperglicemia and nitric oxide bioavailability play a pivotal role in pro-atherogenic vascular modifications. |
| Q36807957 | Chronic insulin treatment amplifies PDGF-induced motility in differentiated aortic smooth muscle cells by suppressing the expression and function of PTP1B |
| Q37011769 | Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations |
| Q47605037 | Constitutive modeling of human femoropopliteal artery biaxial stiffening due to aging and diabetes. |
| Q36296605 | Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells |
| Q37580907 | Contribution of insulin resistance to vascular dysfunction. |
| Q38014565 | Cyclophilin-A: a potential screening marker for vascular disease in type-2 diabetes. |
| Q34350546 | Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature |
| Q37643127 | Diabetes and arterial extracellular matrix changes in a porcine model of atherosclerosis |
| Q37486465 | Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions |
| Q43740242 | Diabetes-related changes in cAMP response element-binding protein content enhance smooth muscle cell proliferation and migration. |
| Q34830905 | Diabetes-related microvascular and macrovascular diseases in the physical therapy setting |
| Q26778017 | Diabetic Cardiovascular Disease Induced by Oxidative Stress |
| Q34542793 | Differential regulation of human aortic smooth muscle cell proliferation by monocyte-derived macrophages from diabetic patients |
| Q37083092 | Does Elevated Glucose Promote Atherosclerosis? Pros and Cons |
| Q38845518 | Epigenetic Changes in Diabetes and Cardiovascular Risk. |
| Q43088814 | Erythrocyte protoporphyrin fluorescence as a potential marker of diabetes |
| Q36955509 | Exogenous H2S modulates mitochondrial fusion-fission to inhibit vascular smooth muscle cell proliferation in a hyperglycemic state |
| Q43283572 | Expression of constitutively active cGMP-dependent protein kinase inhibits glucose-induced vascular smooth muscle cell proliferation |
| Q36899626 | Expression of conventional and novel glucose transporters, GLUT1, -9, -10, and -12, in vascular smooth muscle cells |
| Q28576589 | Gas6-axl receptor signaling is regulated by glucose in vascular smooth muscle cells |
| Q79828891 | High glucose concentrations alter hypoxia-induced control of vascular smooth muscle cell growth via a HIF-1alpha-dependent pathway |
| Q24314950 | High glucose decreases endothelial cell proliferation via the extracellular signal regulated kinase/p15(INK4b) pathway |
| Q44298309 | High glucose potentiates mitogenic responses of cultured ovine coronary smooth muscle cells to platelet derived growth factor and transforming growth factor-beta1. |
| Q90650768 | Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome |
| Q44044520 | Hyperglycemia enhances VSMC proliferation with NF-kappaB activation by angiotensin II and E2F-1 augmentation by growth factors. |
| Q34459819 | Increase in GLUT1 in Smooth Muscle Alters Vascular Contractility and Increases Inflammation in Response to Vascular Injury |
| Q36955142 | Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway |
| Q43278861 | Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and Type 2 diabetic patients |
| Q27011696 | Insulin resistance, hyperglycemia, and atherosclerosis |
| Q35871387 | Insulin resistance, metabolic stress, and atherosclerosis |
| Q34988827 | Involvement of peroxisome proliferator-activated receptors in cardiac and vascular remodeling in a novel minipig model of insulin resistance and atherosclerosis induced by consumption of a high-fat/cholesterol diet |
| Q47578992 | Lactate Promotes Synthetic Phenotype in Vascular Smooth Muscle Cells |
| Q50634164 | Lean and obese pig breeds exhibit differences in prenatal gene expression profiles of muscle development. |
| Q24337408 | Long-chain acyl-CoA synthetase 4 modulates prostaglandin E₂ release from human arterial smooth muscle cells |
| Q28573063 | Mechanical stretch augments insulin-induced vascular smooth muscle cell proliferation by insulin-like growth factor-1 receptor |
| Q91218206 | MicroRNAs 342 and 450 together with NOX-4 activity and their association with coronary artery disease in diabetes |
| Q26782445 | Molecular Pathways Regulating Macrovascular Pathology and Vascular Smooth Muscle Cells Phenotype in Type 2 Diabetes |
| Q36687948 | Monocyte chemoattractant protein-1--a major contributor to the inflammatory process associated with diabetes |
| Q34084895 | Nestin downregulation in rat vascular smooth muscle cells represents an early marker of vascular disease in experimental type I diabetes |
| Q44748745 | Nitric oxide attenuates insulin- or IGF-I-stimulated aortic smooth muscle cell motility by decreasing H2O2 levels: essential role of cGMP. |
| Q44077331 | Oleate and linoleate enhance the growth-promoting effects of insulin-like growth factor-I through a phospholipase D-dependent pathway in arterial smooth muscle cells |
| Q44640723 | Oleate, not ligands of the receptor for advanced glycation end-products, promotes proliferation of human arterial smooth muscle cells |
| Q80362512 | Oxidative stress and diabetic vascular complications |
| Q35684097 | Oxidized LDL and Fructosamine Associated with Severity of Coronary Artery Atherosclerosis in Insulin Resistant Pigs Fed a High Fat/High NaCl Diet |
| Q28087462 | Pathogenesis of diabetic cerebral vascular disease complication |
| Q26799591 | Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes |
| Q33276559 | Phenotype-specific inhibition of the vascular smooth muscle cell cycle by high glucose treatment |
| Q34016115 | Plasma protein growth arrest-specific 6 levels are associated with altered glucose tolerance, inflammation, and endothelial dysfunction |
| Q33737777 | Profilin-1 Is Expressed in Human Atherosclerotic Plaques and Induces Atherogenic Effects on Vascular Smooth Muscle Cells |
| Q38023858 | Proinflammatory effects of C-Peptide in different tissues |
| Q36049201 | Reactive oxygen and nitrogen species in pathogenesis of vascular complications of diabetes |
| Q90600159 | Recovery of Cardiac Remodeling and Dysmetabolism by Pancreatic Islet Injury Improvement in Diabetic Rats after Yacon Leaf Extract Treatment |
| Q36416215 | Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models? |
| Q33642252 | Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-gamma-independent mechanism in human arterial smooth muscle cells and macrophages. |
| Q44163968 | Semicarbazide-sensitive amine oxidase in aortic smooth muscle cells mediates synthesis of a methylglyoxal-AGE: implications for vascular complications in diabetes |
| Q36521113 | Swine models of type 2 diabetes mellitus: insulin resistance, glucose tolerance, and cardiovascular complications |
| Q38103313 | The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes? |
| Q36125083 | Type II Diabetes Mellitus in Arabic-Speaking Countries |
| Q33599923 | Vinpocetine attenuates neointimal hyperplasia in diabetic rat carotid arteries after balloon injury |
Search more.